Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Piperazines
  7. L-745,870 trihydrochloride, Tocris Bioscience™

L-745,870 trihydrochloride, Tocris Bioscience™
GREENER_CHOICE

Catalog No. 100250
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

Highly selective D4 antagonist

A highly potent and selective D4 dopamine receptor antagonist; L-745,870 has Ki values of 0.51, 2300 and 960 nM for D4, D3 and D2 subtypes respectively and > 1000-fold selectivity over 5-HT2, D1 and D5 receptors.

Chemical Identifiers

CAS 866021-03-6
Molecular Formula C18H22Cl4N4
Molecular Weight (g/mol) 436.202
InChI Key KJSOYZLYCFYXFC-UHFFFAOYSA-N
Synonym l-745,870 trihydrochloride, 3-4-4-chlorophenyl piperazin-1-yl methyl-1h-pyrrolo 2,3-b pyridine trihydrochloride, 3-4-4-chlorophenyl piperazin-1-yl-methyl-1h-pyrrolo 2,3-b pyridine trihydrochloride, 3-4-4-chlorophenyl piperazin-1-yl-methyl-1h-pyrrolo 2,3-b pyridine tri hydrochloride
PubChem CID 49759035
IUPAC Name 3-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine;trihydrochloride
SMILES C1CN(CCN1CC2=CNC3=C2C=CC=N3)C4=CC=C(C=C4)Cl.Cl.Cl.Cl

Specifications

Quantity 50 mg
Formula Weight 436.21
Percent Purity >99%
Chemical Name or Material L-745, 870 trihydrochloride

Safety and Handling

Recommended Storage Desiccate at +4°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.